Detection of Previously Unidentified Metastatic Disease as a Leading Cause of Screening Failure in a Phase III Trial of Zibotentan Versus Placebo in Patients with Nonmetastatic, Castration Resistant Prostate Cancer
Titel:
Detection of Previously Unidentified Metastatic Disease as a Leading Cause of Screening Failure in a Phase III Trial of Zibotentan Versus Placebo in Patients with Nonmetastatic, Castration Resistant Prostate Cancer
Auteur:
Yu, Evan Y. Miller, Kurt Nelson, Joel Gleave, Martin Fizazi, Karim Moul, Judd W. Nathan, Faith E. Higano, Celestia S.
Verschenen in:
The journal of urology
Paginering:
Jaargang 188 (2012) nr. 1 pagina's 7 p.
Jaar:
2012
Inhoud:
Uitgever:
American Urological Association Education and Research, Inc.